Sorrento Therapeutics, Inc. (SRNEQ) Stock Analysis
DELISTED
What happened to Sorrento Therapeutics, Inc. (SRNEQ) stock?
Sorrento Therapeutics, Inc. (SRNEQ) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $16.5M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Sorrento Therapeutics, Inc. (SRNEQ). Sorrento Therapeutics, Inc. is a clinical and commercial stage biopharmaceutical company focused on developing treatments for cancer, infectious diseases, and pain. The company filed for Chapter 11 reorganization in February 2023.
Last analyzed: Mar 17, 2026Sorrento Therapeutics, Inc. (SRNEQ) Healthcare & Pipeline Overview
SRNEQ OTC Market Information
SRNEQ trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy SRNEQ shares?
No. SRNEQ stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for SRNEQ elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before SRNEQ stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Sorrento Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.